Ubs Group Ag Edwards Lifesciences Corp Put Options Transaction History

Ubs Group Ag

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $843,000 - $943,100	10,000 New	10,000 $923,000
Q3 2023 Nov 09, 2023	BUY	$69.28 - $93.38 $2.08 Million - $2.8 Million	30,000 Added 92.02%	62,600 $4.34 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $2.65 Million - $3.08 Million	32,600 New	32,600 $3.08 Million
Q4 2022 Feb 08, 2023	BUY	$68.3 - $87.44 $20,490 - $26,232	300 New	300 $22,000
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $3.08 Million - $3.88 Million	30,200 Added 15100.0%	30,400 $3.58 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $10,637 - $13,068	-100 Reduced 33.33%	200 $26,000
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $415,802 - $529,134	-5,800 Reduced 95.08%	300 $27,000
Q1 2020 May 01, 2020	BUY	$52.41 - $81.0 $309,219 - $477,900	5,900 Added 2950.0%	6,100 $1.15 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $6,155 - $7,543	100 Added 100.0%	200 $44,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $111,480 - $128,820	-2,000 Reduced 95.24%	100 $18,000
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $23,945 - $32,025	500 Added 31.25%	2,100 $402,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $4,570 - $5,803	100 Added 6.67%	1,600 $278,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $63,675 - $76,950	-1,500 Reduced 50.0%	1,500 $218,000
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $6,758 - $7,878	-200 Reduced 6.25%	3,000 $338,000
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $29,032 - $31,064	-800 Reduced 20.0%	3,200 $350,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,000	4,000 $473,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.